3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Lung Neoplasms
4
Multiple Pulmonary Nodules
2
Colorectal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Solitary Pulmonary Nodule
1
Smoking Cessation
1
Small Cell Lung Carcinoma
1
Recurrence
1
Melanoma
1
Lymphoma, Follicular
1
Lung Diseases
1
Inflammatory Bowel Diseases
1
Head and Neck Neoplasms
1
Glioma
1
Depressive Disorder, Major
1
Breast Neoplasms
1
Breast Neoplasm Female
1
Bone Neoplasms
1
Barrett Esophagus
1
Adenocarcinoma of Lung
1
Adenocarcinoma
1
Interventions
Ibandronic Acid
5
Zoledronic Acid
3
Denosumab
3
pembrolizumab
2
Sunitinib
2
Radiotherapy, Intensity-Modulated
2
Nivolumab
2
Methods
2
Interviews as Topic
2
Injections
2
Curettage
2
selinexor
1
saracatinib
1
ridaforolimus
1
radium Ra 223 dichloride
1
pegfilgrastim
1
olaparib
1
montanide ISA 51
1
lentiviral minigene vaccine of COVID-19 coronavirus
1
endostar protein
1
cc-486
1
angiotensin I (1-7)
1
Vincristine
1
Transplantation, Homologous
1
Transplantation, Autologous
1
Transcranial Direct Current Stimulation
1
Trabectedin
1
Tomography, Spiral Computed
1
TES
1
Surveys and Questionnaires
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Bone Neoplasms
×
Diagnostic Imaging
×
Clear all
NCT04884048
2023-06-06
BTI-RADS M
Central Hospital, Nancy, France
Completed
1,100 enrolled